Newman, MA, United States of America

Daniel Elbaum

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Discovering the Innovations of Inventor Daniel Elbaum

Introduction

Daniel Elbaum, a dedicated inventor based in Newman, Massachusetts, has made significant contributions to the field of medicinal chemistry, particularly in the development of therapies for cystic fibrosis. With a total of two patents to his name, he has demonstrated his commitment to innovation in this critical area of healthcare.

Latest Patents

Elbaum's recent patents revolve around the use of pyrrolopyrimidines as CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) potentiators. The first patent details methods of using the compounds of Formula I, aimed at enhancing the function of defective CFTR proteins in cystic fibrosis patients. The second patent focuses on the compounds themselves, again encompassing those described in Formula I, signifying a dual approach to address this genetic disorder.

Career Highlights

Throughout his career, Daniel Elbaum has been associated with prominent organizations such as the Cystic Fibrosis Foundation and Cystic Fibrosis Foundation Therapeutics, Inc. His tenure at these institutions has facilitated his access to necessary resources and platforms for his research, allowing him to bridge the gap between laboratory discoveries and clinical applications for better patient outcomes.

Collaborations

Elbaum has collaborated with esteemed colleagues in the field, including Joseph Walter Strohbach and David Christopher Limburg. These partnerships have likely enriched his work, combining different perspectives and expertise to advance the innovations surrounding cystic fibrosis treatments.

Conclusion

In summary, Daniel Elbaum's contributions to the field of cystic fibrosis therapeutics through his innovative patents and collaborations signify his important role as an inventor. His work not only aids in understanding CFTR modulators but also paves the way for improved therapies for patients suffering from this challenging condition. As he continues to navigate the landscape of medicinal chemistry, Elbaum's innovations hold promise for even greater advancements in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…